Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zongming Song

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Journal of Genetics and Genomics = Yi Chuan Xue Bao|June 23, 2018
Functional non-homologous end joining patterns triggered by CRISPR/Cas9 in human cellsFayu Yang, Xianglian Ge, Xiubin He, et al.
Journal of Ophthalmology|May 6, 2021
Management of Vasoproliferative Tumors of the Retina with Macular Complications by Pars Plana Vitrectomy Combined with Episcleral CryotherapyWenhua Zhang, Zeyuan Qiang, Hao Song, et al.
Ageing Research Reviews|December 5, 2025
cGAS-STING-driven inflammaging cascade in aging-related retinal diseases: From pathological mechanism to therapeutic potentialsXiaosu Wang, Zhihui Feng, Sa Sun, et al.
Materials Today. Bio|December 4, 2025
From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeuticsMengli Sun, Jiale Wang, Wenhui Fan, et al.
Biotechnology Journal|March 16, 2018
SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human CellsHaihua Xie, Lianchao Tang, Xiubin He, et al.
Cell Regeneration (London, England)|November 12, 2019
Efficient cleavage resolves PAM preferences of CRISPR-Cas in human cellsLianchao Tang, Fayu Yang, Xiaoxue He, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
CRISPR/Cas9-loxP-Mediated Gene Editing as a Novel Site-Specific Genetic Manipulation ToolFayu Yang, Changbao Liu, Ding Chen, et al.
Biotechnology Journal|December 17, 2017
SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human CellsHaihua Xie, Lianchao Tang, Xiubin He, et al.
Experimental Eye Research|April 25, 2015
A novel imidazopyridine derivative, X22, prevents the retinal ischemia-reperfusion injury via inhibition of MAPKsYang Bian, Luqing Ren, Lei Wang, et al.
Aging and Disease|March 13, 2026
Targeting the Gut-Retina Axis in Age-Related Retinopathies: Microbiome-Immunometabolic Pathways and Gerotherapeutic PerspectivesZhihui Feng, Kexin Wang, Xiaosu Wang, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Journal of Genetics and Genomics = Yi Chuan Xue Bao|June 23, 2018
Functional non-homologous end joining patterns triggered by CRISPR/Cas9 in human cellsFayu Yang, Xianglian Ge, Xiubin He, et al.
Journal of Ophthalmology|May 6, 2021
Management of Vasoproliferative Tumors of the Retina with Macular Complications by Pars Plana Vitrectomy Combined with Episcleral CryotherapyWenhua Zhang, Zeyuan Qiang, Hao Song, et al.
Ageing Research Reviews|December 5, 2025
cGAS-STING-driven inflammaging cascade in aging-related retinal diseases: From pathological mechanism to therapeutic potentialsXiaosu Wang, Zhihui Feng, Sa Sun, et al.
Materials Today. Bio|December 4, 2025
From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeuticsMengli Sun, Jiale Wang, Wenhui Fan, et al.
Biotechnology Journal|March 16, 2018
SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human CellsHaihua Xie, Lianchao Tang, Xiubin He, et al.
Cell Regeneration (London, England)|November 12, 2019
Efficient cleavage resolves PAM preferences of CRISPR-Cas in human cellsLianchao Tang, Fayu Yang, Xiaoxue He, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
CRISPR/Cas9-loxP-Mediated Gene Editing as a Novel Site-Specific Genetic Manipulation ToolFayu Yang, Changbao Liu, Ding Chen, et al.
Biotechnology Journal|December 17, 2017
SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human CellsHaihua Xie, Lianchao Tang, Xiubin He, et al.
Experimental Eye Research|April 25, 2015
A novel imidazopyridine derivative, X22, prevents the retinal ischemia-reperfusion injury via inhibition of MAPKsYang Bian, Luqing Ren, Lei Wang, et al.
Aging and Disease|March 13, 2026
Targeting the Gut-Retina Axis in Age-Related Retinopathies: Microbiome-Immunometabolic Pathways and Gerotherapeutic PerspectivesZhihui Feng, Kexin Wang, Xiaosu Wang, et al.
Pageof 9